Breast Tumour Proliferation and Endocrine Therapy Effects
Author Information
Author(s): N.G. Coldham, L.C. Lai, M.J. Reed, M.W. Ghilchik, N.A. Shaikh, V.H.T. James
Primary Institution: St Mary's Hospital Medical School
Hypothesis
How does DNA polymerase a activity relate to breast tumour proliferation and the effects of endocrine therapy?
Conclusion
DNA polymerase a activity is significantly lower in benign breast tumours compared to malignant ones, and endocrine therapy reduces this activity in some patients.
Supporting Evidence
- DNA polymerase a activity was significantly higher in malignant tumours than in benign ones.
- Six out of seven patients treated with MPA showed reduced DNA polymerase a activity after treatment.
- 67% of the tumours were oestrogen receptor positive, with a mean binding of 91 fmol mg protein.
Takeaway
This study looked at how a specific enzyme related to cell growth in breast tumours and how treatment affected it. They found that benign tumours grow less than malignant ones.
Methodology
Breast tumour samples were obtained from women, and DNA polymerase a activity was measured before and after endocrine therapy.
Limitations
The study had a small sample size and focused only on specific types of breast cancer treatments.
Participant Demographics
30 women with untreated malignant tumours and 16 women with benign tumours, mostly postmenopausal.
Statistical Information
P-Value
p<0.025
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website